J Korean Diabetes Assoc.
1999 Dec;23(6):831-842.
Relation of Angiotensin Converting Enzyme (ACE) Gene Polymorphism to Insulin Sensitivity and Carotid
Atherosclerosis in Female Nondiabetic Offspring of NIDDM Patients
Abstract
-
BACKGROUND: Angiotensin converting enzyme (ACE) gene polymorphism has been known to related to atherosclerotic heart
disease such as acute myocardial infarction or left ventricular hypertrophy, diabetic nephropathy or retinopathy,
as well as, insulin sensitivity. However, an exact relationship between ACE gene polymorphism and aforementioned
diseases have not been fully established. It has been suggested that NIDDM and atherosclerosis may have common
pathogenesis since some of NIDDM patients already have atherosclerotic changes at the time of the initial diagnosis.
Futhermore, offspring of NIDDM patients are considered as a high risk group for both NIDDM and atherosclerosis, and
these two disorders are known to be affected by some common genetic factors. Therefore, in the present study, we
planned to investigate, by analyzing female offspring of NIDDM patients (offspring), the relationship of ACE gene
polymorphism to insulin resistance and atherosclerosis. METHODS: Fifty-three female offspring of patients with NIDDM
were participated in this study, and twenty age-BMI matched normal glucose tolerant subjects without a family history
of diabetes were selected as the controls. Based on 75-g oral glucose tolerance test, subjects were divided into normal
glucose tolerance (n=42) or impaired glucose tolerance (n=ll). We assessed the patterns of body fat distribution by
anthropometric measurement, bioelectric impedence analysis and computed tomogram; insulin sensitivity by minimal model
analysis using insulin modified frequently sampled intravenous glucose tolerance test; carotid intima-medial thickness
by ultrasonography. We investigated the alleles of the ACE gene by PCR. RESULT: 1. ACE genotypes in offspring were
distributed as follows; 39.6% for II, 32.0% for ID, 28.4% for DD 55.7% for I al#lele, 44.3% for D allele. This
distribution was not significantly different from those in controls (35.0% for II, 55.0% for ID, 10.0% for DD, 62.5% for
I allele, and 37.5% for D allele). 2. There was no significant difference in body mass index (BMI), systolic and diastolic
blood pressure, and serum lipid concentrations among three genotypes. However, in the subjects with ID genotype,
VSR was significantly increased compared to the subjects with DD genotype (p<0.05). In the subjects with ID genotype,
percent body fat, visceral fat area, CIMT were increased, and SI and SG were decreased in comparison to II and DD
subjects, although the differences between the two groups did not reached the statistical significance. 3.
When the subjects were divided into quartiles of CIMT, the frequency of ID genotype of ACE showed the tendency of
increment from the lowest to the highest quartile of CIMT. 4. Multiple regression analysis showed that ACE genotypes
was significantly associated with visceral obesity, carotid intima-medial thickening and insulin sensitivity.
CONCLUSION
ACE genotypes was not significantly associated with visceral obesity, carotid intima- medial thickening
and insulin sensitivity. However, to explore the true associations of ACE gene polymorphism with insulin resistance
and ather-osclerosis, we further suggest and recommend prospective studies.